|
Thursday, November 15, 2012
Print Current Day:
 |
|
| SESSION 11 SCHEDULE | |
|
Thursday
SESSION 11:
PROGRESS IN TRANSCATHETER HEART VALVES, NEW APPROACHES TO THE ASCENDING AORTA AND THORACIC AORTIC DISEASE (5-MINUTE TALKS)
|
|
| x | |
| 6:30 AM - 6:35 AM | Opening Remarks |
| Presenter(s):Frank J. Veith, MD | |
| 6:35 AM - 6:40 AM | Transcatheter Aortic Valve Implantation (TAVI) For Unsatisfactory Surgical Valve Implantations: Will It Be An Exception Or The Routine In The Future |
| Presenter(s):Dietmar H. Koschyk, MD | |
| View Abstract | |
| 6:41 AM - 6:46 AM | Why Vascular Surgeons Must Play A Role In TAVI Procedures: Why Is Their Expertise Important |
| Presenter(s):Marc R.H. van Sambeek, MD, PhD | |
| View Abstract | |
| 6:47 AM - 6:52 AM | New Developments In Transcutaneous Mitral Valve Repair |
| Presenter(s):Ted Feldman, MD | |
| 6:53 AM - 6:58 AM | Present Status And Future Potential Of TAVI |
| Presenter(s):Martin B. Leon, MD | |
| 6:59 AM - 7:04 AM | Wrapping Procedure For Dilated Ascending Aorta: When And How To Do It |
| Presenter(s):Mario Lachat, MD | |
| 7:05 AM - 7:10 AM | Status Of Endovascular Graft Repair For Aortic Arch Lesions: What Endovascular Solutions Are Working And What Are Not Working |
| Presenter(s):Linda M. Reilly, MD / Timothy A.M. Chuter, DM | |
| 7:11 AM - 7:16 AM | Quantifying Ascending Aorta And Arch Deformation From Respiratory And Cardiac Motion: Implications For Branched Devices |
| Presenter(s):Ronald L. Dalman, MD | |
| 7:17 AM - 7:22 AM | Retrograde Dissection During Endovascular Treatment Of Aortic Arch Pathology: How Can It Be Prevented And Treated |
| Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD | |
| View Abstract | |
| 7:23 AM - 7:28 AM | Risk Factors Of Stroke In Thoracic Endovascular Aortic Repair (TEVAR) And How To Offset Them |
| Presenter(s):Wei Guo Fu, MD | |
| 7:29 AM - 7:34 AM | Hybrid Rescue Techniques For Failed TEVAR Procedures |
| Presenter(s):Eric E. Roselli, MD | |
| 7:35 AM - 7:41 AM | Panel Discussion |
| END OF SESSION 11 | |
| SESSION 12 SCHEDULE | |
|
Thursday
SESSION 12:
NEW DEVELOPMENTS IN TREATMENT OF THE ASCENDING AORTA, ARCH LESIONS AND AORTIC DISSECTIONS (5-MINUTE TALKS)
Moderators:Larry H. Hollier, MD / Richard P. Cambria, MD
|
|
| x | |
| 7:41 AM - 7:46 AM | Future Of Endovascular Treatment Of Ascending Aortic Lesions |
| Presenter(s):Christoph A. Nienaber, MD, PhD | |
| 7:47 AM - 7:52 AM | Unusual Access Routes To The Ascending Aorta And Arch For Endograft Placement: Advantages, Limitations And Precautions |
| Presenter(s):Tilo Koelbel, MD, PhD | |
| 7:53 AM - 7:58 AM | Experience With Endograft Treatment Of Ascending Aortic Lesions And Type A Dissections |
| Presenter(s):Robert J. Hinchliffe, MD / Matt M. Thompson, MD | |
| View Abstract | |
| 7:59 AM - 8:04 AM | Endovascular Graft Treatment Of Type A Dissections: Technique And In What Proportion Of Patients Will It Be Possible |
| Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD | |
| 8:05 AM - 8:10 AM | Complete Endovascular Graft Exclusion Of Arch Aneurysms Using A Non-Custom-Made Branched Arch Device (Cook) |
| Presenter(s):Krassi Ivancev, MD, PhD | |
| View Abstract | |
| 8:11 AM - 8:16 AM | New Developments In Endovascular Repair Of Zone 0 Aortic Arch Pathologies |
| Presenter(s):Toru Kuratani, MD, PhD | |
| View Abstract | |
| 8:17 AM - 8:22 AM | Experience With The Bolton Arch Branch Endograft |
| Presenter(s):W. Anthony Lee, MD | |
| 8:23 AM - 8:28 AM | Advantages Of A Precurved Fenestrated Endograft For Treating Arch Aneurysms And Dissections |
| Presenter(s):Yoshihiko Yokoi, MD | |
| View Abstract | |
| 8:29 AM - 8:34 AM | Hybrid (Open And Endo) Treatment Of Aortic Arch Aneurysms And Dissections: How Laparoscopy Can Help In Evaluating Patients With Malperfusion |
| Presenter(s):Roberto Chiesa, MD | |
| View Abstract | |
| 8:35 AM - 8:40 AM | Update On In Situ Fenestration For Arch Repair: Will Endovascular Total Arch Repair Replace Open Techniques |
| Presenter(s):Bjõrn Sonesson, MD, PhD | |
| View Abstract | |
| 8:41 AM - 8:47 AM | Panel Discussion |
| END OF SESSION 12 | |
| SESSION 13 SCHEDULE | |
|
Thursday
SESSION 13:
PROGRESS IN TREATING DISEASES OF THE THORACIC AORTA, INCLUDING DISSECTIONS AND MANAGING COMPLICATIONS (5-MINUTE TALKS)
Moderators:Ronald M. Fairman, MD / Christoph A. Nienaber, MD, PhD
|
|
| x | |
| 8:47 AM - 8:52 AM | Open Surgical vs. Endovascular Treatment Of Thoracic Aortic Pathology In Marfan’s Syndrome: Is Endo Safe And When |
| Presenter(s):Roberto Chiesa, MD | |
| 8:53 AM - 8:58 AM | TEVAR For Type B Aortic Dissections In Marfan’s Syndrome Can Work |
| Presenter(s):Chang Shu, MD | |
| View Abstract | |
| 8:59 AM - 9:04 AM | When Is TEVAR Contraindicated And Open Repair Needed With Thoracic Aortic Lesions |
| Presenter(s):Michael J. Jacobs, MD | |
| 9:05 AM - 9:10 AM | What Is In And What Is Out With Type B Aortic Dissections And Their Endovascular Treatment |
| Presenter(s):Zhong Gao Wang, MD | |
| View Abstract | |
| 9:11 AM - 9:16 AM | Long-Term (5-Year) Data On Aortic Remodeling After TEVAR Treatment Of Type B Aortic Dissection Supports Early Intervention |
| Presenter(s):Mark Conrad, MD / Richard P. Cambria, MD | |
| 9:17 AM - 9:22 AM | When Is TEVAR Inadequate Treatment For Type B Aortic Dissections |
| Presenter(s):Götz M. Richter, MD, PhD | |
| 9:23 AM - 9:28 AM | DEBATE: Revascularization Of The Left Subclavian: When It Is Covered During TEVAR Matters: But Only With Aneurysms Not With Dissections |
| Presenter(s):Robert J. Hinchliffe, MD / Matt M. Thompson, MD | |
| View Abstract | |
| 9:29 AM - 9:34 AM | DEBATE: Revascularization Of The Left Subclavian: When It Is Covered During TEVAR Only Matters In Exceptional Circumstances |
| Presenter(s):Thomas S. Maldonado, MD | |
| 9:35 AM - 9:40 AM | DEBATE: Routine Revascularization Of The Left Subclavian For All Zone 2 TEVARs Is Unnecessary And Probably Harmful |
| Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
| 9:41 AM - 9:46 AM | Managing Progression Of Aortic Disease After TEVAR: Open Surgery Will Always Be Needed For Some Thoracic And Thoracoabdominal Aneurysms |
| Presenter(s):Hazim J. Safi, MD | |
| 9:47 AM - 9:54 AM | Panel Discussion Conclusion of Program A |
| 9:54 AM - 10:11 AM | Break - Visit Exhibits and Pavilions (2nd and 3rd Floors) |
| END OF SESSION 13 | |
| SESSION 14 SCHEDULE | |
|
Thursday
SESSION 14:
LOWER EXTREMITY HOT TOPICS I (5-MINUTE TALKS)
Moderators:Enrico Ascher, MD / Bruce J. Brener, MD
|
|
| x | |
| 6:35 AM - 6:40 AM | Opening Remarks |
| Presenter(s):Frank J. Veith, MD | |
| 6:40 AM - 6:45 AM | DEBATE: 2-3 Year Comparison Of Sirolimus Eluting Stents (SESs) vs. Bare Metal Stents (BMSs) For Below-Knee And Tibial Occlusive Disease (YUKON Trial) |
| Presenter(s):Gunnar Tepe, MD | |
| 6:46 AM - 6:51 AM | DEBATE: Drug Eluting Balloons (DEBs) Are Better For Below-Knee Lesions Than SESs: 1-Year Results |
| Presenter(s):Francesco Liistro, MD | |
| 6:52 AM - 6:57 AM | Use Of 4 French Systems For Treating Fem-Pop Lesions: Advantages And Disadvantages: Lessons From The 4EVER Trial Using Astron Pulsar Stents And No Closure Devices |
| Presenter(s):Koen Deloose, MD / Marc Bosiers, MD | |
| View Abstract | |
| 6:58 AM - 7:03 AM | New Developments In Distal Puncture Techniques For Treating CTOs Of Lower Extremity Arteries: The Funnel Balloon Catheter; 3 Fr Sheath; Needle Extensions And COR Balloons |
| Presenter(s):Andrej Schmidt, MD | |
| 7:04 AM - 7:09 AM | Best Treatment Of Popliteal Lesions: Stent vs. PTA: The ETAP Trial |
| Presenter(s):Thomas Zeller, MD | |
| 7:10 AM - 7:15 AM | Value Of The Biodegradable Balloon Expandable Remedy Stent For Lower Extremity Lesions: The GAIA Trial Results |
| Presenter(s):Dierk Scheinert, MD | |
| 7:16 AM - 7:21 AM | Does Atherectomy Help To Treat Resistant Calcified SFA Lesions: Does It Require A Distal Filter For Safety |
| Presenter(s):Daniel G. Clair, MD | |
| 7:22 AM - 7:27 AM | DEBATE: Current Role Of New Atherectomy Devices: They Work And Justify The Costs |
| Presenter(s):James F. McKinsey, MD | |
| 7:28 AM - 7:33 AM | DEBATE: Debulking With Atherectomy And Laser Is A Good Idea Whose Time Has Passed |
| Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
| 7:34 AM - 7:40 AM | Panel Discussion |
| END OF SESSION 14 | |
| SESSION 15 SCHEDULE | |
|
Thursday
SESSION 15:
LOWER EXTREMITY HOT TOPICS II (5-MINUTE TALKS)
Moderators:Kenneth Ouriel, MD, MBA, FACS, FACC / Evan C. Lipsitz, MD
|
|
| x | |
| 7:40 AM - 7:45 AM | Long-Term Evaluation (To 5 Years) Of SFA Stents In 1000 Patients: Importance Of TASC Classification, Stent Type And Lesion Length (Belgian/German Study) |
| Presenter(s):Marc Bosiers, MD / Giovanni Torsello, MD / Patrick Peeters, MD | |
| 7:46 AM - 7:51 AM | The Many Uses And Advantages Of The Supera Veritas Stent (IDEV) To Treat Femoropopliteal Lesions |
| Presenter(s):Peter C.J. Goverde, MD / Dierk Scheinert, MD | |
| 7:52 AM - 7:57 AM | 1-Year Results Of The Protege Everflex Stent (ev3) To Treat Popliteal Lesions: DURABILITY-POP Study |
| Presenter(s):Patrick Peeters, MD | |
| 7:58 AM - 8:03 AM | DEBATE: CFA And DFA Occlusive Lesions Are Best Treated By Endovascular Techniques |
| Presenter(s):Thomas Zeller, MD | |
| 8:04 AM - 8:09 AM | DEBATE: How Should CFA And DFA Occlusive Lesions Best Be Treated |
| Presenter(s):Gustavo S. Oderich, MD, FACS | |
| 8:10 AM - 8:15 AM | Extreme Approaches To CTOs via Retrograde Puncture Of Pedal Loop And Digital Arteries: How To Do It |
| Presenter(s):Marco G. Manzi, MD | |
| 8:16 AM - 8:21 AM | DEBATE: Stenting Is Still First Line Treatment For SFA Occlusive Disease |
| Presenter(s):Erich Minar, MD | |
| 8:22 AM - 8:27 AM | DEBATE: Why Should Metal Be Avoided In The SFA And How To Do It |
| Presenter(s):Giancarlo Biamino, MD, PhD | |
| 8:28 AM - 8:33 AM | How To Remove Small Procedural Emboli From Tibial Arteries |
| Presenter(s):Andrej Schmidt, MD | |
| 8:34 AM - 8:39 AM | What To Do For CLI Patients When There Are No Patent Outflow Arteries: Can DEBs Help |
| Presenter(s):Roberto Ferraresi, MD | |
| 8:40 AM - 8:46 AM | Panel Discussion |
| END OF SESSION 15 | |
| SESSION 16 SCHEDULE | |
|
Thursday
SESSION 16:
LOWER EXTREMITY HOT TOPICS III (5-MINUTE TALKS)
Moderators:Jacques Busquet, MD / Luis A. Sanchez, MD
|
|
| x | |
| 8:46 AM - 8:51 AM | DEBATE: Atherectomy And DEBs For Native Disease And In Stent Restenosis In The SFA And Popliteal: Stents Can Be Avoided Completely |
| Presenter(s):Thomas Zeller, MD | |
| 8:52 AM - 8:57 AM | DEBATE: DEBs Won’t Do The Job Alone: Stents Will Be Needed Sometimes For Recoil Or Dissection |
| Presenter(s):Dierk Scheinert, MD | |
| 8:58 AM - 9:03 AM | The Tack-It Device: An Endovascular Stapler For Imperfect PTAs To Avoid Stenting |
| Presenter(s):Peter A. Schneider, MD | |
| View Abstract | |
| 9:04 AM - 9:09 AM | 3-Year Results Of The RESILIENT Trial With The Lifestent: Are The Results Of SFA Stents Durable |
| Presenter(s):John R. Laird, MD | |
| 9:10 AM - 9:15 AM | 3-Year Results From The ZILVER PTX Drug Eluting Stent (DES) Trial: Are The Results Durable And How Do Patterns Of Restenosis Differ |
| Presenter(s):Michael D. Dake, MD / Gary M. Ansel, MD | |
| 9:16 AM - 9:21 AM | 2-Year Outcomes Of Stent Supported PTA For Iliac Lesions: Balloon vs. Self-Expanding Stents: Influence Of TASC Classification: The BRAVISSIMO Trial |
| Presenter(s):Patrick Peeters, MD | |
| 9:22 AM - 9:27 AM | DEBATE: To Treat Lower Extremity Chronic Total Occlusions (CTOs) One Only Needs A Wire And A Catheter And Not All This Expensive Nonsense |
| Presenter(s):Amman Bolia, MD | |
| View Abstract | |
| 9:28 AM - 9:33 AM | DEBATE: We Need All This Stuff And More To Meet Unmet Needs With Lower Extremity Occlusive Disease |
| Presenter(s):Gary M. Ansel, MD | |
| 9:34 AM - 9:39 AM | How To Use A Radiofrequency Wire To Cross Difficult CTOs: Advantages, Precautions, Limitations |
| Presenter(s):Marcelo S. Guimaraes, MD | |
| 9:40 AM - 9:45 AM | ALL CLI Is Not The Same: This And Diabetic Status Render Limb Salvage Rates A Poor Index Of Success With Revascularization Procedures: Some Limbs With CLI Survive With Conservative Treatment And Prayer |
| Presenter(s):Francesco Serino, MD | |
| 9:46 AM - 9:54 AM | Panel Discussion Conclusion of Joint Sessions with VEITHsymposium. VEITHsymposium continues after the Break in the Grand Ballroom, 3rd Floor. AIMsymposium continues at 10:00 a.m. |
| 9:54 AM - 10:10 AM | Break - Visit Exhibits and Pavilions (2nd and 3rd Floors) |
| END OF SESSION 16 | |
| SESSION 17 SCHEDULE | |
|
Thursday
SESSION 17:
NEW DEVELOPMENTS IN SFA AND CRURAL ARTERY TREATMENT AND MANAGEMENT OF CRITICAL LIMB ISCHEMIA (CLI) (5-MINUTE TALKS)
Moderators:Frank J. Veith, MD / Barry T. Katzen, MD
|
|
| x | |
| 10:10 AM - 10:15 AM | Why Is Duplex For Guidance For Lower Extremity Endovascular Procedures Not Replacing Fluoroscopy: Duplex Is So Much Better |
| Presenter(s):Enrico Ascher, MD | |
| 10:16 AM - 10:21 AM | 13 Steps To Successful Pedal Access |
| Presenter(s):Craig M. Walker, MD | |
| 10:22 AM - 10:27 AM | Drug Eluting Balloons (DEBs) Really Work: Comparative Results Prove It: When And Where Are DEBs Indicated |
| Presenter(s):Gunnar Tepe, MD | |
| 10:28 AM - 10:33 AM | How Have DEBs Changed Lower Extremity Interventional Practice In Germany: Above And Below The Knee |
| Presenter(s):Andrej Schmidt, MD | |
| 10:34 AM - 10:39 AM | How DEBs Have Changed Lower Extremity Interventional Practice In Italy: Are They Worth The Increased Cost |
| Presenter(s):Giancarlo Biamino, MD, PhD | |
| 10:40 AM - 10:45 AM | Drug-Eluting Stents For Focal Infrapopliteal Lesions: Meta-analysis Of The ACHILLES, DESTINY And YUKON-BTX Trials |
| Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR | |
| View Abstract | |
| 10:46 AM - 10:51 AM | Differences In Amputation Rates Following Treatment For Tissue Loss (Gangrene) And Rest Pain: Their Importance In Trials Evaluating Stem Cell And Other New Treatments |
| Presenter(s):Thomas F. O'Donnell, Jr., MD | |
| View Abstract | |
| 10:52 AM - 10:57 AM | Why Are DESs Not Going To Work In CLI Patients Based On The Anatomy Of Their Lesions |
| Presenter(s):Nicolas A. Diehm, MD | |
| 10:58 AM - 11:03 AM | The Case For Subintimal PTA Above And Below The Inguinal Ligament |
| Presenter(s):George H. Meier III, MD | |
| 11:04 AM - 11:09 AM | Open Bypass Procedures Have Value And Can Work When Endovascular Interventions Have Failed: What Percentage Of CLI Patients Will Need A Bypass: Endo First Is Not The Way To Go In Some Patients Since Bridges Are Burned |
| Presenter(s):Francesco Spinelli, MD | |
| View Abstract | |
| 11:10 AM - 11:15 AM | Pedal Bypasses Are Definitely Superior To PTA For Long Tibial Lesions |
| Presenter(s):Werner Lang, MD | |
| 11:16 AM - 11:21 AM | Wound Related And Flow Guided Treatment For CLI With Necrotic Foot Lesions |
| Presenter(s):Roberto Ferraresi, MD | |
| 11:22 AM - 11:27 AM | DEBATE: The Case For The Angiosome Concept |
| Presenter(s):Richard F. Neville, MD | |
| 11:28 AM - 11:33 AM | DEBATE: The Angiosome Concept Is Not Important Except Possibly In Dialysis Patients |
| Presenter(s):Nobuyoshi Azuma, MD | |
| View Abstract | |
| 11:34 AM - 11:39 AM | DEBATE: A Patent Pedal Arch Is More Important Than The Angiosome Concept: But Foot Healing Can Occur Without An Intact Pedal Arch |
| Presenter(s):Hisham Rashid, MSc, FRCS, FRCS(Gen) | |
| View Abstract | |
| 11:40 AM - 11:45 AM | Indocyanine Green Angiography: A Method To Study The Angiosome Concept |
| Presenter(s):Joseph L. Mills, MD | |
| 11:46 AM - 11:51 AM | Stem Cell Therapy Will Have An Increasing Role In The Treatment Of CLI: It Really Works And A Glimpse Into The Future: Based On The RESTORE CLI Phase 2b Trial |
| Presenter(s):Richard J. Powell, MD | |
| 11:54 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break – Americas Hall I, 3rd Floor Visit Exhibits and Pavilions (2nd and 3rd Floors) |
| END OF SESSION 17 | |
| SESSION 18 SCHEDULE | |
|
Thursday
SESSION 18:
NEW DEVELOPMENTS IN TEVAR AND EVAR (5-MINUTE TALKS)
Moderators:Juan C. Parodi, MD / Hazim J. Safi, MD
|
|
| x | |
| 1:00 PM - 1:05 PM | Axillofemoral Bypass To Prevent Limb Ischemia During Prolonged Iliac Sheath Occlusion For Complex EVARs |
| Presenter(s):Krassi Ivancev, MD, PhD | |
| View Abstract | |
| 1:06 PM - 1:11 PM | Lessons Learned And Precautions Needed With Fenestrated And Branched Grafts For Complex Aneurysm Repairs |
| Presenter(s):Piotr M. Kasprzak, MD | |
| 1:12 PM - 1:17 PM | Pathogenesis Of Spinal Cord Ischemia (SCI) During TEVAR And Open Repair: Is It The Same Or Different: Implications For Prevention And Treatment |
| Presenter(s):Charles W. Acher, MD | |
| 1:18 PM - 1:23 PM | How To Prevent SCI After TEVAR |
| Presenter(s):Michael J. Jacobs, MD | |
| 1:24 PM - 1:29 PM | Tips And Tricks For Performing CSF Drainage Optimally With TEVAR Or Open Repair |
| Presenter(s):Vicente Riambau, MD, PhD | |
| View Abstract | |
| 1:30 PM - 1:35 PM | DEBATE: Endovascular Graft Treatment Of Acute Uncomplicated Type B Aortic Dissection May Not Be A Good Idea: Medical Treatment May Be As Good (Video) |
| Presenter(s):Sebastian E. Debus, MD, PhD | |
| 1:36 PM - 1:41 PM | DEBATE: Experience With Early TEVAR Treatment Of Uncomplicated Type B Aortic Dissection: It Really Is The Right Thing To Do Based On False Lumen/True Lumen Measurements |
| Presenter(s):Rodney A. White, MD | |
| 1:42 PM - 1:47 PM | Long-Term (3-5 Year) Results Of The INSTEAD Trial Shows The Benefit Of Early TEVAR Treatment Of Uncomplicated Type B Aortic Dissections: Game Changing Results |
| Presenter(s):Christoph A. Nienaber, MD, PhD | |
| 1:48 PM - 1:53 PM | Results Of TEVAR In Acute Type B Aortic Dissection vs. Best Medical Treatment: First Results Of The ADSORB Trial: A Randomized Controlled Trial |
| Presenter(s):Jan S. Brunkwall, MD, PhD | |
| 1:54 PM - 1:59 PM | Some Concerns After Aortic Endografting For Type B Aortic Dissections |
| Presenter(s):Stephen W.K. Cheng, MBBS | |
| 2:00 PM - 2:05 PM | How Valuable Are The Aptus HeliFX Staples (EndoAnchors): Results From The ANCHOR Registry |
| Presenter(s):William D. Jordan, Jr., MD | |
| View Abstract | |
| 2:06 PM - 2:12 PM | Panel Discussion |
| END OF SESSION 18 | |
| SESSION 19 SCHEDULE | |
|
Thursday
SESSION 19:
CRITICAL EVALUATION OF CAROTID ARTERY STENTING (CAS) IN NOVEMBER 2012: WHERE IS IT AND WHERE IS IT GOING
Moderators:Giorgio M. Biasi, MD / Frank J. Veith, MD
|
|
| x | |
| 2:12 PM - 2:17 PM | Why MRI Should Be Done Before All Revascularization Procedures (CAS And CEA): Duplex Is Not Enough |
| Presenter(s):Emmanuel M. Houdart, MD | |
| 2:18 PM - 2:23 PM | Closed vs. Open Cell Stents For CAS: The Number Of Embolic Particles Are No Greater Nor Are Outcomes Worse With Open Cell Stents |
| Presenter(s):Peter L. Faries, MD, FACS | |
| 2:24 PM - 2:29 PM | CAS For Total Carotid Occlusion: It Can Work And Be Beneficial: Under What Circumstances |
| Presenter(s):Paul H.L. Kao, MD | |
| 2:30 PM - 2:35 PM | DEBATE: CAS Is Good Treatment For Most Patients With Symptomatic And Asymptomatic Carotid Stenosis |
| Presenter(s):Klaus D. Mathias, MD | |
| 2:36 PM - 2:41 AM | DEBATE: CAS Is Not Good Treatment For Most Patients With Symptomatic And Asymptomatic Carotid Stenosis |
| Presenter(s):Bruce A. Perler, MD, MBA | |
| View Abstract | |
| 2:42 PM - 2:47 PM | Is Current Best Medical Treatment (BMT) Feasible And Does It Work To Decrease Strokes From Intracranial Disease In A High Risk Population: Results From The SAMMPRIS Trial Suggest BMT Can Decrease Strokes Markedly |
| Presenter(s):Marc Chimowitz, MD | |
| 2:48 PM - 2:53 PM | Analysis Of CREST By A Neuroradiologist: What Is The Significance Of A Minor Stroke |
| Presenter(s):Emmanuel M. Houdart, MD | |
| 2:54 PM - 2:59 PM | DEBATE: Cardiac Events Are An Appropriate End-Point For Evaluating CAS vs. CEA Outcomes; And In CREST, CAS Results Improved With Time |
| Presenter(s):William A. Gray, MD | |
| 3:00 PM - 3:05 PM | DEBATE: Cardiac Events Are Not An Appropriate End-Point For Evaluating CAS vs. CEA Outcomes; And In CREST, CAS Results Did Not Improve With Time |
| Presenter(s):Wesley S. Moore, MD | |
| View Abstract | |
| 3:06 PM - 3:11 PM | Interventions Performed Within 1 Week Of A Neurological Event: Outcomes Of CEA Are Better Than CAS |
| Presenter(s):Hans-Henning Eckstein, MD, PhD | |
| 3:12 PM - 3:17 PM | The Case Against Embolic Protection Devices In CAS: Why Therefore Are They So Widely Used |
| Presenter(s):Michel S. Makaroun, MD | |
| 3:18 PM - 3:23 PM | Meta-Analysis Of CAS By Cervical Access Shows Dramatic Reduction In Neurological Events |
| Presenter(s):Patrice F. Bergeron, MD / Petrosian Andranik, MD | |
| 3:24 PM - 3:29 PM | A Specialized Device For Performing CAS Via A Cervical Approach With Flow Reversal (FAST-CAS System): Early Results From The PROOF Trial |
| Presenter(s):Ralf R. Kolvenbach, MD | |
| View Abstract | |
| 3:30 PM - 3:35 PM | DEBATE: Why Is It Difficult To Randomize Asymptomatic Carotid Stenosis Patients To A 3-Armed Trial: CEA vs. CAS vs. BMT |
| Presenter(s):Hans-Henning Eckstein, MD, PhD | |
| 3:36 PM - 3:41 PM | DEBATE:Why We Must Have A Trial Comparing BMT To CAS And CEA In Asymptomatic Patients With Carotid Stenosis |
| Presenter(s):Anne L. Abbott, MD, PhD, FRACP, FRACP | |
| View Abstract | |
| 3:42 PM - 3:47 PM | TCD Embolic Signals, Silent Infarcts On CT-Brain Scans, Or The Size Of Juxtaluminal Black Area In Evaluating Stroke Potential Of Asymptomatic Carotid Lesions |
| Presenter(s):Andrew N. Nicolaides, MS, FRCS | |
| View Abstract | |
| 3:48 PM - 4:00 PM | Panel Discussion And Break Visit Exhibits and Pavilions (2nd and 3rd Floors) |
| END OF SESSION 19 | |
| SESSION 20 SCHEDULE | |
|
Thursday
SESSION 20:
NEW DEVELOPMENTS IN LOWER EXTREMITY STENT-GRAFTS (5-MINUTE TALKS)
Moderators:Mark A. Adelman, MD / Darren B. Schneider, MD
|
|
| x | |
| 4:00 PM - 4:05 PM | Patency Of Viabahn Stent Grafts Is Better Than Bare Metal Stents For SFA Occlusive Disease: Final Results Of The VIASTAR Trial |
| Presenter(s):Johannes Lammer, MD | |
| 4:06 PM - 4:11 PM | Are Stent Grafts The Solution For In-Stent Restenosis After SFA Stenting |
| Presenter(s):Marc Bosiers, MD / Koen Deloose, MD | |
| View Abstract | |
| 4:12 PM - 4:17 PM | Technical Considerations To Improve Results With SFA Stent-Grafting For Occlusive Disease: Lessons Learned From The VIPER Trial With Heparin-Bonded Viabahn Stent-Grafts |
| Presenter(s):Richard R. Saxon, MD | |
| View Abstract | |
| 4:18 PM - 4:23 PM | Why Do Viabahn Stent-Grafts Fail In The First Year: Does Collateral Coverage And Antiplatelet Treatment Matter |
| Presenter(s):Michael S. Conte, MD | |
| 4:24 PM - 4:29 PM | Standard Fempop Bypasses Are Better Than Endoluminal Stent-Graft “Bypasses” For 5-25 cm SFA Occlusions: An Older RCT: Is It Still Relevant |
| Presenter(s):Mauri J.A. Lepantalo, MD | |
| View Abstract | |
| 4:30 PM - 4:35 PM | Current Status Of Heparin Bonded Viabahn Stent-Grafts Based On European Studies |
| Presenter(s):Thomas Zeller, MD | |
| 4:36 PM - 4:41 PM | Current Status Of Viabahn Endografts For Treatment Of Popliteal Aneurysms: Which Patients Should Not Be Treated Endovascularly |
| Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
| View Abstract | |
| 4:42 PM - 4:47 PM | Can Covered Stents Safely Be Placed Across The Inguinal Ligament And In The CFA |
| Presenter(s):Keith D. Calligaro, MD | |
| View Abstract | |
| 4:48 PM - 4:55 PM | Panel Discussion |
| END OF SESSION 20 | |
| SESSION 21 SCHEDULE | |
|
Thursday
SESSION 21:
NEW OR IMPROVED CONCEPTS IN VASCULAR DISEASE TREATMENT AND THE CONTROVERSY OVER THE INTERVENTIONAL TREATMENT OF CCSVI FOR MULTIPLE SCLEROSIS (5-MINUTE TALKS)
Moderators:Bruce A. Perler, MD, MBA / Jean-Baptiste Ricco, MD, PhD
|
|
| x | |
| 4:55 PM - 5:00 PM | Tips And Tricks For Vascular Disease Intervention In Pediatric Patients |
| Presenter(s):Furuzan Numan, MD | |
| 5:01 PM - 5:06 PM | DEBATE: Update On The Treatment Of Vasculogenic Impotence: Viagra, Cialis And Levitra Are Most Often Enough |
| Presenter(s):Ralph G. DePalma, MD | |
| View Abstract | |
| 5:07 PM - 5:12 PM | DEBATE: Not True, Some Patients Need Internal Pudendal Stenting: Current Status Of The Endovascular Treatment Of Erectile Dysfunction |
| Presenter(s):Krishna J. Rocha-Singh, MD | |
| View Abstract | |
| THE CCSVI CONTROVERSY IN MULTIPLE SCLEROSIS | |
| 5:13 PM - 5:18 PM | What’s New In The Diagnosis And Endovascular Treatment Of CCSVI In MS Patients |
| Presenter(s):Paolo Zamboni, MD | |
| 5:19 PM - 5:24 PM | Endovascular Treatment Of CCSVI In MS Patients Really Works: The Benefits Of Treating Venous Brain Congestion Can Be Documented |
| Presenter(s):Ivo Petrov, MD, PhD | |
| 5:25 PM - 5:30 PM | Does Interventional Treatment Help MS Patients: A Skeptical Vascular Surgeon Remains Skeptical |
| Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
| 5:31 PM - 5:36 PM | Intrinsic And Extrinsic Cerebrospinal Venous Abnormalities In Neurological Diseases: Anatomic And Physiological Evidence |
| Presenter(s):Michael D. Dake, MD | |
| 5:37 PM - 5:42 PM | Interventional Treatment Of CCSVI Can Improve MS: A Vascular Surgeon Who Is Convinced |
| Presenter(s):Manish Mehta, MD, MPH | |
| 5:43 PM - 5:48 PM | DEBATE: The Case Against Treating CCSVI In MS Patients |
| Presenter(s):Emmanuel M. Houdart, MD | |
| 5:49 PM - 5:54 PM | DEBATE: The Case For Treating CCSVI In MS Patients |
| Presenter(s):Donald B. Reid, MD | |
| 5:55 PM - 6:00 PM | DEBATE: Venous Angioplasty For MS Is Voodoo Medicine |
| Presenter(s):Mark H. Wholey, MD | |
| 6:01 PM - 6:06 PM | Panel Discussion |
| END OF SESSION 21 | |
| SESSION 22 SCHEDULE | |
|
Thursday
SESSION 22:
NEW OR BETTER TECHNIQUES FOR TREATING ENDOLEAKS AND OTHER EVAR AND TEVAR TOPICS (5-MINUTE TALKS)
Moderators:Timur P. Sarac, MD / Luis A. Sanchez, MD
|
|
| x | |
| 6:06 PM - 6:11 PM | How And When Is It Safe To Treat Type I Endoleaks After EVAR Non-Interventionally: A 13-Year Experience |
| Presenter(s):James May, MD, MS, FRACS, FACS | |
| View Abstract | |
| 6:12 PM - 6:17 PM | How Embolization With Onyx Can Be An Effective Solution For Type I Endoleaks And Other Novel Solutions For Endoleaks After EVAR And TEVAR |
| Presenter(s):Robert A. Morgan, MD | |
| 6:18 PM - 6:23 PM | Long-Term Follow-up Of Treated Type II Endoleaks Shows The Need For Close Surveillance And Frequent Re-Treatment |
| Presenter(s):Timur P. Sarac, MD | |
| 6:24 PM - 6:29 PM | When Does Translumbar Glue Embolization Of Type II Endoleaks Work And When Does It Not: Tips And Tricks To Make It Effective |
| Presenter(s):Neal S. Cayne, MD | |
| 6:30 PM - 6:35 PM | Tips And Tricks On How To Use Onyx In The Treatment Of Type I And Other Major Endoleaks |
| Presenter(s):Thomas Larzon, MD | |
| 6:36 PM - 6:41 PM | The Anaconda Fenestrated Graft For Juxtarenal AAAs: Advantages, Limitations And 1-Year Registry Results |
| Presenter(s):Nick J. Burfitt, BSc, MB, BChir, MRCS, FRCR | |
| View Abstract | |
| 6:42 PM - 6:47 PM | Interplay Between Anatomy And Indications/Pathology In TEVAR Outcomes: Anatomic Complexity Drives Outcomes More Than Pathology/Indications |
| Presenter(s):Michael C. Stoner, MD | |
| View Abstract | |
| 6:48 PM - 6:55 PM | Panel Discussion Conclusion of Program C. |
| END OF SESSION 22 | |
| SESSION 23 SCHEDULE | |
|
Thursday
SESSION 23:
LOWER EXTREMITY ADDITIONAL TOPICS (4-MINUTE TALKS)
Moderators:Peter L. Faries, MD, FACS / Ross Milner, MD
|
|
| x | |
| 1:00 PM - 1:04 PM | Bringing Atherectomy To The Next Level: What Is Its Future |
| Presenter(s):Jos C. van den Berg, MD, PhD | |
| 1:05 PM - 1:09 PM | Optical Coherence Tomography Of The Femoral Arteries: How Is It Done And What Is Its Value |
| Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR | |
| View Abstract | |
| 1:10 PM - 1:14 PM | Will Plaque Excision By Atherectomy Become The Treatment Of Choice For Popliteal Occlusive Disease: 1-Year Results From The DEFINITIVE LE Trial In 800 Patients |
| Presenter(s):James F. McKinsey, MD | |
| 1:15 PM - 1:19 PM | The True Path Rotating Tip Device For Crossing Chronic Total Occlusion (CTO): How Does It Work And How Well Does It Work |
| Presenter(s):John R. Laird, MD | |
| 1:20 PM - 1:24 PM | Relevance Of In-Stent Restenosis In Various Territories And Best Strategies For Treatment |
| Presenter(s):John R. Laird, MD | |
| 1:25 PM - 1:29 PM | Laser Debulking And DEB For In-Stent Restenosis |
| Presenter(s):Jos C. van den Berg, MD, PhD | |
| 1:30 PM - 1:34 PM | The Wildcat Catheter From Avinger In Crossing Difficult Aortoiliac Occlusions |
| Presenter(s):Patrick E. Muck, MD, FACS | |
| View Abstract | |
| 1:35 PM - 1:39 PM | Status Of Biodegradable Stents And Will They Work In The Periphery |
| Presenter(s):Ron Waksman, MD | |
| 1:40 PM - 1:44 PM | Long-Term Results Of The ABSORB Trial Showing Benefits Of Biodegradable Coronary Stents: When Will We Know If They Will Work Elsewhere |
| Presenter(s):Lewis B. Schwartz, MD | |
| 1:45 PM - 1:49 PM | Heparin Bonded Bypass Grafts, Stent-Grafts And Hybrid Grafts: Will They Make A Difference |
| Presenter(s):Edward Y. Woo, MD | |
| View Abstract | |
| 1:50 PM - 1:54 PM | Improved 3-Year Patency Of Heparin Bonded PTFE Grafts vs. PTFE Grafts Without Heparin |
| Presenter(s):Russell H. Samson, MD, RVT, FACS | |
| 1:55 PM - 1:59 PM | Best Treatment For In-Stent Restenosis After Renal Artery Stenting |
| Presenter(s):Robert A. Lookstein, MD, FSIR, FAHA | |
| 2:00 PM - 2:04 PM | Current Optimal Treatment For Long SFA Occlusions |
| Presenter(s):Gary M. Ansel, MD | |
| 2:05 PM - 2:09 PM | Tips And Tricks For Successful Stent-Graft Treatment Of Popliteal Aneurysms |
| Presenter(s):Irwin V. Mohan, MD, FRCS, FEBVS, FRACS | |
| View Abstract | |
| 2:10 PM - 2:14 PM | Is Functional Popliteal Entrapment A Myth Or Reality |
| Presenter(s):Cynthia K. Shortell, MD | |
| 2:15 PM - 2:19 PM | Prior Contralateral Major Amputation Predicts Worse Outcomes For Lower Extremity Revascularization In The Intact Limb |
| Presenter(s):Andres Schanzer, MD | |
| 2:20 PM - 2:24 PM | Outcomes Of Single Segment Greater Saphenous Vein Graft Bypasses Are Better Than Those Of Alternative Autologous Vein Bypasses |
| Presenter(s):Mauri J.A. Lepantalo, MD | |
| View Abstract | |
| 2:25 PM - 2:30 PM | Panel Discussion |
| END OF SESSION 23 | |
| SESSION 24 SCHEDULE | |
|
Thursday
SESSION 24:
ADDITIONAL THORACIC AND ABDOMINAL AORTA TOPICS (4-MINUTE TALKS)
Moderators:Jerry Goldstone, MD, FACS, FRCSEd / Gary Giangola, MD
|
|
| x | |
| 2:30 PM - 2:34 PM | How Much Does Stent Design Matter For The Various Thoracic Aortic Pathologies: What Are The Unmet Needs |
| Presenter(s):Michael D. Dake, MD | |
| 2:35 PM - 2:39 PM | Initial Experience With Ascending Aortic Endografting Using The Cook Endograft For Type A Dissection |
| Presenter(s):Ralf R. Kolvenbach, MD | |
| View Abstract | |
| 2:40 PM - 2:44 PM | Do Distal Bare Stents Have Value In The Treatment Of Type B Aortic Dissections |
| Presenter(s):Burkhart Zipfel, MD | |
| 2:45 PM - 2:49 PM | The Embrella Aortic Arch Embolic Deflector: Does It Work: What Precautions Must Be Used And What Are Its Complications |
| Presenter(s):Jeffrey P. Carpenter, MD | |
| 2:50 PM - 2:54 PM | New Classification System For Blunt Traumatic Aortic Injury To Guide In Conservative Or Endograft Treatment |
| Presenter(s):Benjamin W. Starnes, MD | |
| 2:55 PM - 2:59 PM | Pros And Cons Of Early TEVAR With Extensive Coverage Of The Thoracic Aorta In Type B Aortic Dissections |
| Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
| 3:00 PM - 3:04 PM | Diagrams Showing How To Make Sandwich Grafting Technique Work For Endovascular Treatment Of Thoracoabdominal Aneurysms |
| Presenter(s):Armando C. Lobato, MD, PhD | |
| 3:05 PM - 3:09 PM | How Do Pressure Changes In The Excluded Aneurysm Sac Impact On Spinal Cord Ischemia After TEVAR |
| Presenter(s):Bjõrn Sonesson, MD, PhD | |
| View Abstract | |
| 3:10 PM - 3:14 PM | How Do Outcomes From A Contemporary EVAR Registry (ENGAGE Registry) Differ From Those From Older Registries Like EUROSTAR: EVAR Is Getting Better |
| Presenter(s):Marc R.H. van Sambeek, MD, PhD | |
| 3:15 PM - 3:19 PM | Decreasing Prevalence Of AAAs And Improving Short-Term And Long-Term Outcomes After EVAR In Sweden: What Are The Reasons For Them |
| Presenter(s):Anders Wanhainen, MD, PhD / Martin Bjorck, MD, PhD | |
| 3:20 PM - 3:24 PM | What Is The Annual Rupture Risk Of AAAs That Have Increasing Sac Size After EVAR But No Detectable Endoleak |
| Presenter(s):Frans L. Moll, MD, PhD | |
| 3:25 PM - 3:29 PM | How Well Are The Complex (Fenestrated) Stent-Grafts Doing: UK Multicenter Study |
| Presenter(s):S. Rao Vallabhaneni, MD, FRCS / Richard G. McWilliams, MD | |
| View Abstract | |
| 3:30 PM - 3:34 PM | Optimal Current Treatment Of Infected AAAs: The Role Of Endografts |
| Presenter(s):Kamphol Laohapensang, MD | |
| View Abstract | |
| 3:35 PM - 3:39 PM | 1-Day Surgery For EVAR: Experience In >60 Patients |
| Presenter(s):Zoran Rancic, MD, PhD | |
| 3:40 PM - 3:44 PM | How Well Do Endografts Do In The Treatment Of Aortoduodenal And Aortoesophageal Fistulas: How Can Survival Be Achieved |
| Presenter(s):Bart E. Muhs, MD, PhD | |
| 3:45 PM - 3:49 PM | Tips And Tricks For Managing Difficult Iliac Arteries: Tug-Wire Technique To Overcome Tortuous Arteries And Balloon Slide Technique To Overcome Tiny Arteries |
| Presenter(s):Thomas Larzon, MD | |
| 3:50 PM - 3:59 PM | Panel Discussion |
| END OF SESSION 24 | |
| SESSION 25 SCHEDULE | |
|
Thursday
SESSION 25:
MISCELLANEOUS IMPORTANT TOPICS (4-MINUTE TALKS)
Moderators:Michael D. Dake, MD / Krassi Ivancev, MD, PhD
|
|
| x | |
| THE CCSVI CONTROVERSY IN MULTIPLE SCLEROSIS | |
| 4:00 PM - 4:04 PM | Creation Of A New IVC In A Patient Whose IVC Was Obliterated By Trauma: An Interventional Approach |
| Presenter(s):Thomas A. Sos, MD / Akhilesh Sista, MD | |
| 4:05 PM - 4:09 PM | What’s Happening To The Randomized Trials Comparing Interventional Treatment To Placebo Treatment Of CCSVI In MS Patients |
| Presenter(s):L. Nelson Hopkins, MD | |
| 4:10 PM - 4:14 PM | Incidence Of Internal Jugular Vein Stenosis In Thoracic Outlet Syndrome Patients: How Does This Relate To MS And CCSVI |
| Presenter(s):Sam S. Ahn, MD, MBA, FACS | |
| 4:15 PM - 4:19 PM | Are Venous Anomalies In MS Patients Relevant Or Not |
| Presenter(s):Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
| View Abstract | |
| 4:20 PM - 4:24 PM | MS And CCSVI: Is The Relationship Real And Causally Important |
| Presenter(s):Andrew N. Nicolaides, MS, FRCS | |
| View Abstract | |
| 4:25 PM - 4:29 PM | Improving Contemporary Usage And Techniques Result In Better Patency With Nitinol SFA Stents (Smart Stents): Based On The STROLL Trial |
| Presenter(s):Marc H. Glickman, MD | |
| MORE ABOUT ABDOMINAL AND THORACOABDOMINAL ANEURYSMS | |
| 4:30 PM - 4:34 PM | New Classification Of Suprarenal Aneurysms Based On Location Of The Proximal Seal Zone: Correlates With Mortality And Morbidity Of Fenestrated And Branched Endografts |
| Presenter(s):Krassi Ivancev, MD, PhD | |
| View Abstract | |
| 4:35 PM - 4:39 PM | Is Medical Treatment To Slow Growth Of AAAs Effective: The STOPS Trial |
| Presenter(s):Ronald L. Dalman, MD | |
| 4:40 PM - 4:44 PM | An Improved Method For Measuring AAA Size With EKG Gated 3D Ultrasound |
| Presenter(s):Henrik Sillesen, MD, DMSc | |
| View Abstract | |
| 4:45 PM - 4:49 PM | What Is The "Best" Treatment For Perigraft Hygroma With AAA Sac Enlargement After EVAR |
| Presenter(s):John Blebea, MD, MBA | |
| 4:50 PM - 4:54 PM | Novel Method For Making Cannulation Of The Contralateral Limb Quick (<10 Seconds) And Easy During EVAR |
| Presenter(s):Willem Wisselink, MD | |
| 4:55 PM - 5:00 PM | Panel Discussion |
| MISCELLANEOUS TOPICS | |
| Moderator(s): John B. Chang, MD / Elliot L. Chaikof, MD, PhD | |
| 5:01 PM - 5:05 PM | What Will Happen In The Effort To Separate Doctors From Industry: Predictions For The Future And What Is Happening In Massachusetts |
| Presenter(s):Richard A. Baum, MD, MPA, MBA | |
| 5:06 PM - 5:10 PM | Principles Of Medical Treatment To Prevent Stroke |
| Presenter(s):Anne L. Abbott, MD, PhD, FRACP, FRACP | |
| View Abstract | |
| 5:11 PM - 5:15 PM | Managing Complications Of CAS |
| Presenter(s):Klaus D. Mathias, MD | |
| 5:16 PM - 5:20 PM | Stroke Prevention And PFO Closure: Dead Or Alive |
| Presenter(s):William A. Gray, MD | |
| 5:21 PM - 5:25 PM | Catheter Directed Thrombolysis As Treatment For Acute SMA Occlusion |
| Presenter(s):Bjõrn Sonesson, MD, PhD / Martin Bjorck, MD, PhD / Timothy A. Resch, MD, PhD | |
| 5:26 PM - 5:30 PM | Novel Endovascular Techniques For Treating Complex Iliac Aneurysmal Disease |
| Presenter(s):Joseph L. Mills, MD / Luis R. Leon, MD, RVT, FACS | |
| 5:31 PM - 5:35 PM | Laparoscopic Sutureless Aortobifemoral Bypass Using The Lachat Viabahn (VORTEC) Technique |
| Presenter(s):Ralf R. Kolvenbach, MD | |
| View Abstract | |
| 5:36 PM - 5:40 PM | How Do Long Bare Metal SFA Stents Perform: The DURABILITY Trial Clinical Outcomes, Treadmill Data, Objective Patency, And Routine Stent Fracture Assessment |
| Presenter(s):Jon S. Matsumura, MD | |
| 5:41 PM - 5:45 PM | Homocysteine Is A Predictor Of Vascular Mortality: A Useful Marker Misunderstood |
| Presenter(s):Afshin Assadian, MD | |
| 5:46 PM - 5:51 PM | Use Of Duplex Ultrasound To Facilitate Distal Tibial And Pedal Access To Treat Lower Extremity Occlusive Disease |
| Presenter(s):Jihad A. Mustapha, MD | |
| 5:51 PM - 6:00 PM | Panel Discussion Conclusion of Program D. |
| END OF SESSION 25 | |